ES8202059A1 - Un metodo de preparacion de antigeno superficial de la hepa-titis b - Google Patents

Un metodo de preparacion de antigeno superficial de la hepa-titis b

Info

Publication number
ES8202059A1
ES8202059A1 ES496445A ES496445A ES8202059A1 ES 8202059 A1 ES8202059 A1 ES 8202059A1 ES 496445 A ES496445 A ES 496445A ES 496445 A ES496445 A ES 496445A ES 8202059 A1 ES8202059 A1 ES 8202059A1
Authority
ES
Spain
Prior art keywords
surface antigen
hepatitis
preparing hepatitis
hbsag
incubation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES496445A
Other languages
English (en)
Spanish (es)
Other versions
ES496445A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8202059A1 publication Critical patent/ES8202059A1/es
Publication of ES496445A0 publication Critical patent/ES496445A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES496445A 1979-11-02 1980-10-31 Un metodo de preparacion de antigeno superficial de la hepa-titis b Granted ES496445A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/090,169 US4301250A (en) 1979-11-02 1979-11-02 Method of producing hepatitis B surface antigen

Publications (2)

Publication Number Publication Date
ES8202059A1 true ES8202059A1 (es) 1982-01-16
ES496445A0 ES496445A0 (es) 1982-01-16

Family

ID=22221612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496445A Granted ES496445A0 (es) 1979-11-02 1980-10-31 Un metodo de preparacion de antigeno superficial de la hepa-titis b

Country Status (10)

Country Link
US (1) US4301250A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0028567B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5679625A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE10806T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3069846D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK462280A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES496445A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR70783B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE50695B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT71977B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1177753A (en) * 1980-03-27 1984-11-13 Paul M. Keller Method of growing hepatitis b surface antigen background of the invention
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4301249A (en) * 1980-07-23 1981-11-17 Merck & Co., Inc. High titer production of hepatitis A virus
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4714613A (en) * 1982-09-30 1987-12-22 The Albert Einstein College Of Medicine Of Yeshiva University Method of suppressing cell growth by immunotherapy
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst HBs抗原の精製方法
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
CN104962525A (zh) * 2007-05-04 2015-10-07 巴克斯特国际公司 用于病毒增殖的两阶段温度分布

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
JPS4940925A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-08-26 1974-04-17
JPS5531762B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-03-28 1980-08-20
JPS5127730A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-08-31 1976-03-08 Tokyo Shibaura Electric Co
JPS5822008B2 (ja) * 1975-08-07 1983-05-06 デユフアル・インテルナチオナル・レセ−ルフ・ベ−・ヴエ− 猫のヘルペスウイルスのワクチン
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
ATE10806T1 (de) 1985-01-15
EP0028567B1 (en) 1984-12-19
JPH0156051B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-11-28
US4301250A (en) 1981-11-17
DE3069846D1 (en) 1985-01-31
PT71977B (en) 1982-03-31
IE802262L (en) 1981-05-02
EP0028567A3 (en) 1982-05-26
GR70783B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-03-23
PT71977A (en) 1980-11-01
IE50695B1 (en) 1986-06-25
EP0028567A2 (en) 1981-05-13
JPS5679625A (en) 1981-06-30
ES496445A0 (es) 1982-01-16
DK462280A (da) 1981-05-03

Similar Documents

Publication Publication Date Title
EP0452484A4 (en) Production of proteins using homologous recombination
ES8300473A1 (es) Un metodo de preparacion del antigeno superficial de la hepatitis b.
ES8202059A1 (es) Un metodo de preparacion de antigeno superficial de la hepa-titis b
PT71739A (en) Process for preparing a cell culture of hepatitis a virus
DE3174765D1 (en) High titer production of hepatitis a virus
ES8105384A1 (es) Procedimiento para la produccion de un material de proteina unicelular
NZ183731A (en) Process for culturing cells(microorganism and tissue culture) dependent on the relationship between cycle time and biomass efficiency ratio
GB1443948A (en) Production of immunological material
IE810688L (en) HBsAg FROM A HEPATOMA
PT72015A (en) Process for preparing in vitro culture of hepatitis b virus
NZ178230A (en) In vitro cultivation of vegetale cells using lactose
EP0212444A3 (en) Process of producing highly transformable cells and cells produced thereby
JPS5774086A (en) Callus for plant tissue culture and its cultivation
JPS6461384A (en) Graphite crucible for pulling-up of silicon single crystal
FR2571383B2 (fr) Perfectionnement au procede de preparation du facteur ix a partir de cultures de cellules de mammifere